Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors

1 Views
administrator
administrator
07/13/23

James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors

For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next